Skip to main navigation Skip to search Skip to main content

Dissecting the roles of MicroRNAs in coronary heart disease via integrative genomic analyses

  • Tianxiao Huan
  • , Jian Rong
  • , Kahraman Tanriverdi
  • , Qingying Meng
  • , Anindya Bhattacharya
  • , David D. McManus
  • , Roby Joehanes
  • , Themistocles L. Assimes
  • , Ruth McPherson
  • , Nilesh J. Samani
  • , Jeanette Erdmann
  • , Heribert Schunkert
  • , Paul Courchesne
  • , Peter J. Munson
  • , Andrew D. Johnson
  • , Christopher J. O'Donnell
  • , Bin Zhang
  • , Martin G. Larson
  • , Jane E. Freedman
  • , Daniel Levy
  • Xia Yang
  • Framingham Heart Study
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Boston University
  • National Institutes of Health
  • University of Massachusetts Medical School
  • University of California at Los Angeles
  • Harvard Medical School
  • Stanford University School of Medicine
  • University of Ottawa
  • University of Leicester
  • The National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge
  • University of Lübeck
  • Partner Site Munich Heart Alliance
  • Mount Sinai School of Medicine

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Objective - The roles of microRNAs (miRNAs) in coronary heart disease (CHD) have not been well characterized. This study sought to systematically characterize the complex genomic architecture of CHD by integrating whole blood miRNA and mRNA expression with genetic variation in 186 CHD cases and 186 controls. Approach and Results - At false discovery rate <0.2, 15 miRNAs were differentially expressed between CHD cases and controls. To explore regulatory mechanisms, we integrated miRNA and mRNA expression with genome-wide genotype data to investigate miRNA and mRNA associations and relationships of genetic variation with miRNAs. We identified a large number of correlated miRNA-mRNA pairs and genetic loci that seem to regulate miRNA levels. Subsequently, we explored the relationships of these complex molecular associations with CHD status. We identified a large difference in miRNA-mRNA associations between CHD cases and controls, as demonstrated by a significantly higher proportion of inversely correlated miRNA-mRNA pairs in cases versus controls (80% versus 30%; P<1×10-16), suggesting a genome-wide shift in the regulatory structure of the transcriptome in CHD. The differentially coexpressed miRNA-mRNA pairs showed enrichment for CHD risk genetic variants affecting both miRNA and mRNA expression levels, implicating a putatively causal role in CHD. Furthermore, 3 miRNAs (miR-1275, miR-365a-3p, and miR-150-5p) were associated with an mRNA coexpression module that was causally linked to CHD and reflected the dysregulation of B-cell centered immune function. Conclusions - Our results provide novel evidence that miRNAs are important regulators of biological processes involved in CHD via genetic control and via their tight coexpression with mRNAs.

Original languageEnglish
Pages (from-to)1011-1021
Number of pages11
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume35
Issue number4
DOIs
StatePublished - 27 Apr 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • coronary disease
  • genetics
  • systems biology

Fingerprint

Dive into the research topics of 'Dissecting the roles of MicroRNAs in coronary heart disease via integrative genomic analyses'. Together they form a unique fingerprint.

Cite this